168 related articles for article (PubMed ID: 29430633)
1. Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma.
Prieto-Barrios M; Llamas-Martin R; Velasco-Tamariz V; Calleja-Algarra A; Ruano Y; Ortiz-Romero PL; Rodriguez-Peralto JL
Br J Dermatol; 2018 Nov; 179(5):1163-1167. PubMed ID: 29430633
[TBL] [Abstract][Full Text] [Related]
2. The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
Huang L; Zhang J; Chen F; Zhang X; Cao Y; Cheng R; Deng D
J Dermatol; 2022 Sep; 49(9):921-924. PubMed ID: 35567308
[TBL] [Abstract][Full Text] [Related]
3. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
4. Phacomatosis Pigmentokeratotica: A Mosaic RASopathy with Malignant Potential.
Om A; Cathey SS; Gathings RM; Hudspeth M; Lee JA; Marzolf S; Wine Lee L
Pediatr Dermatol; 2017 May; 34(3):352-355. PubMed ID: 28523882
[TBL] [Abstract][Full Text] [Related]
5. Phacomatosis pigmentokeratotica is a "pseudodidymosis".
Happle R
J Invest Dermatol; 2013 Aug; 133(8):1923-5. PubMed ID: 23856930
[TBL] [Abstract][Full Text] [Related]
6. Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratotica.
Li JY; Berger MF; Marghoob A; Bhanot UK; Toyohara JP; Pulitzer MP
J Cutan Pathol; 2014 Aug; 41(8):663-71. PubMed ID: 24628623
[TBL] [Abstract][Full Text] [Related]
7. Phacomatosis pigmentokeratotica associated with hemihypertrophy and a rhabdomyosarcoma of the abdominal wall.
Gruson LM; Orlow SJ; Schaffer JV
J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S16-20. PubMed ID: 16843117
[TBL] [Abstract][Full Text] [Related]
8. HRAS mutation in phacomatosis pigmentokeratotica without extracutaneous disease.
Jennings L; Cummins R; Murphy GM; Gulmann C; O'Kane M
Clin Exp Dermatol; 2017 Oct; 42(7):791-792. PubMed ID: 28736904
[No Abstract] [Full Text] [Related]
9. Papular nevus spilus syndrome: old and new aspects of a mosaic RASopathy.
Torchia D; Happle R
Eur J Dermatol; 2019 Feb; 29(1):2-5. PubMed ID: 30827948
[TBL] [Abstract][Full Text] [Related]
10. Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation.
Martin RJ; Arefi M; Splitt M; Redford L; Moss C; Rajan N
Br J Dermatol; 2018 Jan; 178(1):289-291. PubMed ID: 28489335
[No Abstract] [Full Text] [Related]
11. Phacomatosis pigmentokeratotica: Postzygotic HRASÂ mutation with malignant degeneration of the sebaceous naevus.
Cranwell WC; Walsh M; Winship I
Australas J Dermatol; 2019 Aug; 60(3):e245-e246. PubMed ID: 30767209
[No Abstract] [Full Text] [Related]
12. Phacomatosis spilosebacea: A new name for a distinctive binary genodermatosis.
Torchia D; Happle R
J Am Acad Dermatol; 2023 Oct; 89(4):764-773. PubMed ID: 33583608
[TBL] [Abstract][Full Text] [Related]
13. A Case of Phacomatosis Pigmentokeratotica Associated With Multiple Basal Cell Carcinomas.
Loh SH; Lew BL; Sim WY
Am J Dermatopathol; 2018 Feb; 40(2):131-135. PubMed ID: 28937433
[TBL] [Abstract][Full Text] [Related]
14. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
Sarin KY; Sun BK; Bangs CD; Cherry A; Swetter SM; Kim J; Khavari PA
JAMA Dermatol; 2013 Sep; 149(9):1077-81. PubMed ID: 23884457
[TBL] [Abstract][Full Text] [Related]
15. Phacomatosis pigmentokeratotica: a further case without extracutaneous anomalies and review of the condition.
Chantorn R; Shwayder T
Pediatr Dermatol; 2011; 28(6):715-719. PubMed ID: 22082467
[TBL] [Abstract][Full Text] [Related]
16. Schimmelpenning-Feuerstein-Mims syndrome induced by HRASÂ Gly12Ser somatic mosaic mutation: Case report and literature review.
Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
[TBL] [Abstract][Full Text] [Related]
17. Phacomatosis pigmentokeratotica without extracutaneous abnormalities: a case study involving a preterm baby.
Oh GN; Kim JY; Choi JE; Ahn HH; Kye YC; Seo SH
J Korean Med Sci; 2012 Nov; 27(11):1444-6. PubMed ID: 23166433
[TBL] [Abstract][Full Text] [Related]
18. Mosaic pathogenic HRAS variant in a patient with nevus spilus with agminated Spitz nevi and parametrial-uterine rhabdomyosarcoma.
Nemeth K; Szabo S; Cottrell CE; McNulty SM; Segura A; Sokumbi O; Browning M; Siegel DH
Br J Dermatol; 2018 Mar; 178(3):804-806. PubMed ID: 29193020
[No Abstract] [Full Text] [Related]
19. HRAS mutation mosaicism causing urothelial cancer and epidermal nevus.
Hafner C; Toll A; Real FX
N Engl J Med; 2011 Nov; 365(20):1940-2. PubMed ID: 22087699
[No Abstract] [Full Text] [Related]
20. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
